A review of clinical studies of bropirimine immunotherapy of carcinoma in situ of the bladder and upper urinary tract

European Urology

Volumn 31, Issue SUPPL. 1, 1997, Pages 20-26

  Sarosdy, M F ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bropirimine; Carcinoma in situ; Immunotherapy; Urinary tract

Indexed keywords

BCG VACCINE; BROPIRIMINE; IMMUNOSTIMULATING AGENT;

BLADDER CARCINOMA; CARCINOMA IN SITU; CLINICAL TRIAL; CONFERENCE PAPER; CYTOLOGY; HUMAN; IMMUNOTHERAPY; META ANALYSIS; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; TUMOR BIOPSY; URINARY TRACT CARCINOMA;

EID: 0031046615     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000474527     Document Type: Conference Paper

References (36)